Standard Biotools (LAB) Net Margin (2016 - 2025)
Historic Net Margin for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to 177.41%.
- Standard Biotools' Net Margin fell 554400.0% to 177.41% in Q3 2025 from the same period last year, while for Sep 2025 it was 67.36%, marking a year-over-year increase of 380500.0%. This contributed to the annual value of 106.0% for FY2024, which is 358000.0% down from last year.
- According to the latest figures from Q3 2025, Standard Biotools' Net Margin is 177.41%, which was down 554400.0% from 153.75% recorded in Q2 2025.
- In the past 5 years, Standard Biotools' Net Margin registered a high of 24.64% during Q4 2021, and its lowest value of 338.39% during Q2 2022.
- In the last 5 years, Standard Biotools' Net Margin had a median value of 70.61% in 2024 and averaged 110.96%.
- Per our database at Business Quant, Standard Biotools' Net Margin skyrocketed by 4581800bps in 2021 and then crashed by -2831200bps in 2022.
- Quarter analysis of 5 years shows Standard Biotools' Net Margin stood at 24.64% in 2021, then tumbled by -213bps to 77.14% in 2022, then increased by 9bps to 70.58% in 2023, then soared by 55bps to 31.49% in 2024, then crashed by -463bps to 177.41% in 2025.
- Its Net Margin stands at 177.41% for Q3 2025, versus 153.75% for Q2 2025 and 63.69% for Q1 2025.